The effect of low molecular weight heparin on survival in patients with cancer

Basit Öğe Kaydı
dc.contributor.authorSaynak, Mert
dc.contributor.authorYurut-Caloglu, Vuslat
dc.contributor.authorBayir, Gulden
dc.contributor.authorCaloglu, Murat
dc.contributor.authorUzal, Cem
dc.date.accessioned2024-06-12T10:51:57Z
dc.date.available2024-06-12T10:51:57Z
dc.date.issued2006
dc.departmentTrakya Üniversitesien_US
dc.description.abstractThe association between cancer and venous thromboembolism (VTE) is well established. Of all new venous tromboembolism, approximately 20% are associated with active malignancy. In these cases, the pathogenic mechanisms of thrombosis involve a complex interaction between tumour cells, the haemostatic system, and charateristics of the patient. Anticoagulants are the mainstay therapy for the prevention and treatment of acute VTE. The natural history of VTE is more agressive and anticoagulant treatment failure is more frequent in cancer patients than in patients without cancer. Recently, the results of new prospective randomized clinical trials to evaluate the effect of low-molecular-weight heparin on cancer survival have become available. The results suggest a benefit from treatment, particularly in patients with nonadvanced disease. However, these results are not conclusive and require further research.en_US
dc.identifier.endpage46en_US
dc.identifier.issn1300-7467
dc.identifier.issue1en_US
dc.identifier.startpage42en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/18544
dc.identifier.volume21en_US
dc.identifier.wosWOS:000439248200006en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isotren_US
dc.publisherKare Publen_US
dc.relation.ispartofTurk Onkoloji Dergisi-Turkish Journal Of Oncologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAnticoagulants/Adverse Effectsen_US
dc.subjectHeparin, Low-Molecular-Weighten_US
dc.subjectNeoplasms/Complications/Drug Therapyen_US
dc.subjectSurvival Analysisen_US
dc.subjectVenous Thrombosis/Drug Therapy/Etiologyen_US
dc.titleThe effect of low molecular weight heparin on survival in patients with canceren_US
dc.typeReview Articleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu